Trials / Recruiting
RecruitingNCT06171113
A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants
A Phase 1, Randomised, Double Blind Placebo-controlled, First Time in Human Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Oral Doses and Food Effect of GSK4024484 in Healthy Adult Participants.
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 156 (estimated)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The primary purpose of the study is to characterise the safety of GSK4024484 in healthy participants within a controlled pharmacokinetic (PK) range, and the effect of food on the study intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GSK4024484C | Doses administrated orally with 240 mL of water. |
| DRUG | Placebo | Doses administrated orally with 240 mL of water. |
Timeline
- Start date
- 2023-12-11
- Primary completion
- 2026-08-07
- Completion
- 2026-08-07
- First posted
- 2023-12-14
- Last updated
- 2026-04-01
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06171113. Inclusion in this directory is not an endorsement.